Paper · 42952496
Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts.
Zhang L and 7 others. Front Endocrinol (Lausanne), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts. Papers, record 42952496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42952496
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts.
- Journal
- Front Endocrinol (Lausanne)
- Year
- 2026
- Publication types
- Journal Article, Comparative Study
- Revised in PubMed
- 2026-10-30
Source PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Biomarkers | Major topic |
| Blood Glucose | Major topic |
| Diabetes Mellitus | Major topic |
| Humans | |
| Female | |
| Male | |
| Glycated Hemoglobin | |
| Cross-Sectional Studies | |
| Middle Aged | |
| Cohort Studies | |
| Nutrition Surveys | |
| Triglycerides | |
| Adult | |
| Aged | |
| Prevalence | |
| Risk Factors | |
| China |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41,358,893 | 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. | Diabetes Care | 2026 | https://conductscience.org/library/papers/41358893 | PubMed |
| 2 | 38,824,007 | The link between diabetes and cardiovascular disease. | Atherosclerosis | 2024 | https://conductscience.org/library/papers/38824007 | PubMed |
| 3 | 30,828,746 | Epidemiology of Diabetes Mellitus and Cardiovascular Disease. | Curr Cardiol Rep | 2019 | https://conductscience.org/library/papers/30828746 | PubMed |
| 4 | 31,722,562 | Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. | Eur J Prev Cardiol | 2019 | https://conductscience.org/library/papers/31722562 | PubMed |
| 5 | 27,881,363 | Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. | BMJ | 2016 | https://conductscience.org/library/papers/27881363 | PubMed |
| 6 | 33,495,378 | Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study. | Neurology | 2021 | https://conductscience.org/library/papers/33495378 | PubMed |
| 7 | 35,524,263 | Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. | Cardiovasc Diabetol | 2022 | https://conductscience.org/library/papers/35524263 | PubMed |
| 8 | 38,851,022 | The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019. | Diabetes Metab Syndr | 2024 | https://conductscience.org/library/papers/38851022 | PubMed |
| 9 | 32,459,609 | Cardiovascular Disease among Patients with Diabetes: The Current Scenario in Saudi Arabia. | Curr Diabetes Rev | 2021 | https://conductscience.org/library/papers/32459609 | PubMed |
| 10 | 37,848,879 | The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/37848879 | PubMed |
1 to 10 of 37
See all 37 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42952496
GET https://conductscience.org/api/papers/v1/42952496/references?page=2